Healthpeak Properties reported first-quarter earnings beats on Tuesday and slightly increased its full-year guidance following strong leasing activity [3].
This performance signals a recovery in the healthcare real estate sector as the company leverages strategic capital allocation and high-value acquisitions to drive growth.
Company management said the results for the quarter ending May 5, 2026, surpassed both top- and bottom-line expectations [3]. The company also adjusted its 2026 adjusted funds from operations (FFO) per share guidance to a range of $1.71 to $1.00 [2].
A key driver of the company's current strategy is the recent completion of the Janus Living IPO. Management said the IPO is expected to be earnings neutral in 2026 due to temporary cash drag, but will become accretive by approximately four cents per share in 2027 [1].
Beyond the IPO, the company focused on physical expansion in California. The Healthpeak CEO said that in early January, the company completed a "once-in-a-decade buying opportunity" at the Gateway campus in South San Francisco for a small fraction of replacement cost [1].
These moves come after some analysts predicted the company would see a year-over-year fall in revenues and FFO per share [3]. However, the actual Q1 results contradicted those projections, showing that strategic leasing and cost-effective acquisitions are offsetting previous headwinds.
The company continues to focus on healthcare facilities across the U.S. to stabilize its portfolio and increase long-term shareholder value.
“Healthpeak delivered Q1 top- and bottom-line beats on Tuesday and lifted its full-year guidance slightly.”
The shift toward accretive assets like the Gateway campus and the strategic spin-off of Janus Living suggests Healthpeak is pivoting toward higher-margin healthcare real estate. By acquiring assets well below replacement cost, the company is positioning itself for significant capital appreciation as the healthcare infrastructure demand grows.
